Jody Konstadt, MD
Dermatology · Scarsdale, NYNPI 1598737967
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Incyte Corporation at 27.0% of the total. 2025 is the largest year on record at $801, more than ten times the $59 reported in 2019. That places this record below the midpoint for dermatology clinicians in NY, where the typical reported total is $2,360.
Across 105 payments — averaging $18.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$537
- Sanofi$312
- AbbVie$253
- Regeneron Healthcare Solutions, Inc.$213
- Johnson & Johnson$127
- Lilly USA, LLC$86
- plus $463 from 15 others
What the payments were for
- Food & beverage$1,991100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 39 | $537 |
| Sanofi | 12 | $312 |
| AbbVie(2 entities) | 14 | $253 |
| Regeneron Healthcare Solutions, Inc. | 9 | $213 |
| Johnson & Johnson | 6 | $127 |
| Lilly USA, LLC | 4 | $86 |
| Amgen | 2 | $55 |
| Sun Pharmaceutical Industries Inc. | 2 | $55 |
| UCB, Inc. | 3 | $55 |
| Novartis | 3 | $52 |
| Janssen Scientific Affairs, LLC | 1 | $45 |
| Botanix SB Inc | 1 | $31 |
| E.r. Squibb & Sons, L.L.C. | 1 | $30 |
| LEO Pharma Inc. | 1 | $27 |
| Journey Medical Corporation | 1 | $22 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| LNHC, Inc | 1 | $15 |
| Mayne Pharma Commercial LLC | 1 | $5 |
How this compares
$1,991 in reported general payments places this provider in the 45th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 72 | $2,899 |
| Fluorouracil | 51 | $2,795 |
| Azelaic Acid | 15 | $1,791 |
| Doxycycline Hyclate | 55 | $1,350 |
| Hydrocortisone | 82 | $967 |
| Minoxidil | 113 | $810 |
| Ketoconazole | 58 | $790 |
| Triamcinolone Acetonide | 54 | $473 |
| Spironolactone | 19 | $305 |
| Mupirocin | 19 | $137 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Scarsdale
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Jeffrey WeinbergKew Gardens$2.3M
- Joshua ZeichnerNew York$2.1M
- Russell CohenOceanside$2.1M
- Jeffrey LaducaAuburn$1.9M
- Emma GuttmanNew York$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.